Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
PL02 - Presidential Symposium including Top 7 Rated Abstracts
- 08:00 - 10:15
- 9/09/2019
- Location: Barcelona (2005)
- IASLC CME Accredited
- Type: Plenary Session
- Track:
- Moderators:Giorgio Vittorio Scagliotti, Ramon Rami-Porta
-
+
PL02.01 - Passing of the IASLC Flag
08:00 - 08:15
- Abstract
No abstract available for this presentation
-
+
PL02.02 - Lung Cancer Screenee Selection by USPSTF Versus PLCOm2012 Criteria – Interim ILST Findings
08:15 - 08:25 | Presenter: Stephen Lam | Author(s): Renelle Myers, Mamta Ruparel, Sukhinder Kaur Atkar-Khattra, Emily Stone, Renne Manser, Annette Maree McWilliams, Paul Fogarty, David CL Lam, John Yee, John Mayo, Christine Dorothy Berg, Sam Janes, Kwun M Fong, Martin Tammemagi
- Abstract
Loading... -
+
PL02.03 - Early Detection of Cancer of the Lung Scotland (ECLS): Trial Results
08:25 - 08:35 | Presenter: Frank Sullivan | Author(s): Stuart Schembri
- Abstract
Loading... -
+
PL02.04 - Blood MicroRNA and LDCT Reduce Unnecessary LDCT Repeats in Lung Cancer Screening: Results of Prospective BioMILD Trial
08:35 - 08:45 | Presenter: Ugo Pastorino | Author(s): Mattia Boeri, Stefano Sestini, Federica Sabia, Mario Silva, Paola Suatoni, Carla Verri, Anna Cantarutti, Nicola Sverzellati, Giovanni Corrao, Alfonso Marchianò, Gabriella Sozzi
- Abstract
Loading... -
+
PL02.05 - Discussant - PL02.02, PL02.03, PL02.04
08:45 - 08:55 | Presenter: Harry J. de Koning
- Abstract
No abstract available for this presentation
-
+
PL02.06 - In Hospital Clinical Efficacy, Safety and Oncologic Outcomes from VIOLET: A UK Multi-Centre RCT of VATS Versus Open Lobectomy for Lung Cancer
08:55 - 09:05 | Presenter: Eric Lim | Author(s): Tim Batchelor, Joel Dunning, Michael Shackcloth, Vladimir Anikin, Babu Naidu, Elizabeth Belcher, Mahmoud Loubani, Vipin Zamvar, Tim Brush, Lucy Dabner, Rosie Harris, Dawn Phillips, Chloe Beard, Holly McKeon, Sangeetha Paramasivan, Daisy Elliott, Alba Realpe Rojas, Elizabeth Stokes, Sarah Wordsworth, Jane Blazeby, Chris Rogers, T Violet Trialists
- Abstract
Loading... -
+
PL02.07 - Discussant - PL02.06
09:05 - 09:10 | Presenter: Jessica S Donington
- Abstract
No abstract available for this presentation
-
+
PL02.08 - Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung Cancers
09:10 - 09:20 | Presenter: Alexander Drilon | Author(s): Geoffrey R Oxnard, Lori Wirth, Benjamin Besse, Oliver Gautschi, Shao Weng Daniel Tan, Herbert H. Loong, Todd Bauer, Yu Jung Kim, Atsushi Horiike, Keunchil Park, Manisha Shah, Caroline McCoach, Lyudmila Bazhenova, Takashi Seto, Marcia Brose, Nathan Pennell, Jared Weiss, Ignacio Matos, Nir Peled, Byoung Chul Cho, Yuichiro Ohe, Karen L Reckamp, Valentina Boni, Miyako Satouchi, Gerald S Falchook, Wallace Akerley, Haruko Daga, Tomohiro Sakamoto, Jyoti D Patel, Nehal Lakhani, Fabrice Barlesi, Mark Burkard, Viola W. Zhu, Victor Moreno, Jacques Medioni, Marc Matrana, Christian Rolfo, Dae Ho Lee, Hovav Nechushtan, Melissa Johnson, Vamsidhar Velcheti, Makoto Nishio, Ryo Toyozawa, Kadoaki Ohashi, Lucy Song, Ji-Youn Han, Alexander Spira, Filippo Guglielmo Maria De Braud, Kristoffer Staal Rohrberg, Shinji Takeuchi, Jun Sakakibara-Konishi, Saiama Waqar, Hirotsugu Kenmotsu, Frederick Wilson, Binoj Nair, Elizabeth Olek, Jennifer Kherani, Kevin Ebata, Edward Zhu, Michele Nguyen, Luxi Yang, Xin Huang, Scott Cruickshank, Stephen Michael Rothenberg, Benjamin J Solomon, Koichi Goto, Vivek Subbiah
- Abstract
Loading... -
+
PL02.09 - National Lung Matrix Trial (NLMT): First Results from an Umbrella Phase II Trial in Advanced Non-Small Cell Lung Cancer (NSCLC)
09:20 - 09:30 | Presenter: Gary William Middleton | Author(s): Sanjay Popat, Peter Fletcher, Yvonne J. Summers, Alastair Greystoke, David Gilligan, Judith Cave, Noelle O'Rourke, Alison Brewster, Elizabeth W. Toy, James Spicer, Joshua Stephen Savage, Rowena Sharpe, Timothy A. Yap, Charles Swanton, Lucinda Billingham
- Abstract
Loading... -
+
PL02.10 - Discussant - PL02.08, PL02.09
09:30 - 09:38 | Presenter: Robert C. Doebele
- Abstract
No abstract available for this presentation
-
+
PL02.11 - Overall Survival with Durvalumab Plus Etoposide-Platinum in First-Line Extensive-Stage SCLC: Results from the CASPIAN Study
09:38 - 09:48 | Presenter: Luis Paz-Ares | Author(s): Yuanbin Chen, Niels Reinmuth, Katsuyuki Hotta, Dmytro Trukhin, Galina Statsenko, Maximilian J. Hochmair, Mustafa Özgüroğlu, Jun Ho Ji, Oleksandr Voitko, Artem Poltoratskiy, Santiago Ponce, Francesco Verderame, Libor Havel, Igor Bondarenko, Andrzej Kazarnowicz, György Losonczy, Nikolay V. Conev, Jon Armstrong, Natalie Byrne, Norah Shire, Haiyi Jiang, Jonathan Goldman
- Abstract
Loading... -
+
PL02.12 - Discussant - PL02.11
09:48 - 09:53 | Presenter: Myung-Ju Ahn
- Abstract
No abstract available for this presentation
-
+
PL02.13 - Q&A
09:53 - 10:15
- Abstract
No abstract available for this presentation
-
+
PR03 - Press Conference
- 10:15 - 11:00
- 9/09/2019
- Location: CC7.1 A&B
- Type: Press Conference
- Track:
-
+
PR03.01 - Summary of Day's Plenary
10:15 - 10:20
- Abstract
No abstract available for this presentation
-
+
PR03.02 - Lung Cancer Screenee Selection by USPSTF Versus PLCOm2012 Criteria – Interim ILST Findings
10:20 - 10:26
- Abstract
No abstract available for this presentation
-
+
PR03.03 - Early Detection of Cancer of the Lung Scotland (ECLS): Trial Results
10:26 - 10:32
- Abstract
No abstract available for this presentation
-
+
PR03.04 - Blood MicroRNA and LDCT Reduce Unnecessary LDCT Repeats in Lung Cancer Screening: Results of Prospective BioMILD Trial
10:32 - 10:38
- Abstract
No abstract available for this presentation
-
+
PR03.05 - In Hospital Clinical Efficacy, Safety and Oncologic Outcomes from VIOLET: A UK Multi-Centre RCT of VATS Versus Open Lobectomy for Lung Cancer
10:38 - 10:44
- Abstract
No abstract available for this presentation
-
+
PR03.06 - Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung Cancers
10:44 - 10:50
- Abstract
No abstract available for this presentation
-
+
PR03.07 - National Lung Matrix Trial (NLMT): First Results from an Umbrella Phase II Trial in Advanced Non-Small Cell Lung Cancer (NSCLC)
10:50 - 10:55
- Abstract
No abstract available for this presentation
-
+
PR03.08 - Overall Survival with Durvalumab Plus Etoposide-Platinum in First-Line Extensive-Stage SCLC: Results from the CASPIAN Study
10:55 - 11:00
- Abstract
No abstract available for this presentation
-
+
CS01 - Controversies in NSCLC OMD
- 11:00 - 12:30
- 9/09/2019
- Location: Colorado Springs (1994)
- IASLC CME Accredited
- Type: Controversy Session
- Track: Oligometastatic NSCLC
- Moderators:Tomoyuki Hishida, Yolande Lievens
-
+
CS01.01 - "Hunting a Ghost for 25 Years – Will We Ever Catch OMD?" - No
03:30 - 03:50 | Presenter: Tom Treasure
- Abstract
Loading... -
+
CS01.02 - "Hunting a Ghost for 25 Years – Will We Ever Catch OMD?" - Yes
11:20 - 11:40 | Presenter: José Belderbos
- Abstract
Loading... -
+
CS01.03 - Technical Reasons of Local Treatment Define the Limits of NSCLC OMD in Terms of Number of Metastases, Not a Fixed Number
11:40 - 12:00 | Presenter: Marta Scorsetti
- Abstract
Loading... -
+
CS01.04 - NSCLC OMD is Defined by a Fixed Maximum Number of Metastases, Not Technical Reasons of Local Treatment
12:00 - 12:20 | Presenter: GAVIN Michael WRIGHT
- Abstract
Loading... -
+
CS01.05 - Q&A
12:20 - 12:30
- Abstract
No abstract available for this presentation
-
+
ES15 - The Management of Cancer Treatment in Thoracic Malignancy
- 11:00 - 12:45
- 9/09/2019
- Location: Amsterdam (2011)
- IASLC CME Accredited
- Type: Educational Session
- Track: Nursing and Allied Professionals
- Moderators:Anne Fraser, Morten Quist
-
+
ES15.01 - Management of Cognitive Changes in Oncology Patients
11:00 - 11:10 | Presenter: Lauren Urwin
- Abstract
No abstract available for this presentation
-
+
ES15.02 - Mary Duffy's Topic
11:10 - 11:20 | Presenter: Mary Duffy
- Abstract
No abstract available for this presentation
-
+
ES15.03 - Toxicities of Radiation and Immunotherapy: What We Know
11:20 - 11:30 | Presenter: Benjamin Lok
- Abstract
Loading... -
+
ES15.04 - Managing Sleep Difficulties and Cancer
11:30 - 11:45 | Presenter: Maria Ftanou
- Abstract
Loading... -
+
ES15.05 - Nursing Role in Managing Toxicity and Expectations of Treatment
11:45 - 12:00 | Presenter: John McPhelim
- Abstract
Loading... -
+
ES15.06 - The Role of Microbiome Restoration in Chemotherapy and Immunotherapy
12:00 - 12:15 | Presenter: Alexandre Chan
- Abstract
Loading... -
+
ES15.07 - Achieving Holistic Care in Hard to Reach Patient Cohorts
12:15 - 12:30 | Presenter: Phemelo Martha Magabanyane
- Abstract
No abstract available for this presentation
-
+
ES15.08 - Q&A
12:30 - 12:45
- Abstract
No abstract available for this presentation
-
+
ES16 - Modern Radiotherapy in Stage III NSCLC
- 11:00 - 12:30
- 9/09/2019
- Location: Dublin (1997)
- IASLC CME Accredited
- Type: Educational Session
- Track: Treatment of Locoregional Disease - NSCLC
- Moderators:Maria Werner Wasik, Alexandra Giraldo
-
+
ES16.01 - Proton Therapy
11:00 - 11:15 | Presenter: Corinne Faivre-Finn
- Abstract
Loading... -
+
ES16.02 - MRI-Based Radiotherapy
11:15 - 11:30 | Presenter: Fiona McDonald
- Abstract
Loading... -
+
ES16.03 - Optimal Integration of Radiotherapy, TKIs and I/O
11:30 - 11:45 | Presenter: Umberto Ricardi
- Abstract
Loading... -
+
ES16.04 - Molecular Biology of Radiation Toxicity
11:45 - 12:00 | Presenter: Fiona Hegi-Johnson
- Abstract
Loading... -
+
ES16.05 - Q&A
12:00 - 12:30
- Abstract
No abstract available for this presentation
-
+
ES17 - Molecular Alterations and Heterogeneity in Mesothelioma
- 11:00 - 12:30
- 9/09/2019
- Location: Tokyo (1982)
- IASLC CME Accredited
- Type: Educational Session
- Track: Mesothelioma
- Moderators:Steven Mutsaers, Emanuela Felley-Bosco
-
+
ES17.01 - Mesothelioma Evolution
11:00 - 11:20 | Presenter: Edward J. Hollox
- Abstract
Loading... -
+
ES17.02 - Molecular Heterogeneity
11:20 - 11:40 | Presenter: Didier Jean
- Abstract
Loading... -
+
ES17.03 - Heterogeneity & Immune Checkpoint Expression
11:40 - 12:00 | Presenter: Aaron S. Mansfield
- Abstract
Loading... -
+
ES17.04 - New Insights into the Molecular Characteristics and Intra-Tumor Heterogeneity of Malignant Pleural Mesothelioma from the MESOMICS Project
12:00 - 12:20 | Presenter: Lynnette Fernandez-Cuesta
- Abstract
Loading... -
+
ES17.05 - Q&A
12:20 - 12:30
- Abstract
No abstract available for this presentation
-
+
ES18 - Acquired Resistance to TKIs: The Rebiopsy Case and the Future Options
- 11:00 - 12:30
- 9/09/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Educational Session
- Track: Targeted Therapy
- Moderators:Teresa Moran, Matteo Giaj Levra
-
+
Introduction/Poll
11:00 - 11:00
- Abstract
No abstract available for this presentation
-
+
ES18.01 - Rebiopsy in Oncogene Addicted NSCLC at Progression
11:00 - 11:20 | Presenter: D. Ross Camidge
- Abstract
Loading... -
+
ES18.02 - When to Switch to a New TKI : Imaging Based Crtieria or Positive Liquid Biopsy?
11:20 - 11:40 | Presenter: James Chih-Hsin Yang
- Abstract
Loading... -
+
ES18.03 - New Strategies to Overcome Resistance in EGFR Mutated NSCLC
11:40 - 12:00 | Presenter: Paul A Bunn, Jr
- Abstract
Loading... -
+
ES18.04 - New Strategies to Overcome Resistance in ALK Rearranged NSCLC
12:00 - 12:20 | Presenter: Sai-Hong Ignatius Ou
- Abstract
Loading... -
+
ES18.05 - Q&A
12:20 - 12:30
- Abstract
No abstract available for this presentation
-
+
MS05 - Novel Biological Pathways and Druggable Targets
- 11:00 - 12:30
- 9/09/2019
- Location: Vancouver (2003)
- IASLC CME Accredited
- Type: Mini Symposium
- Track: Biology
- Moderators:Jin Jen, Marisol Arroyo-Hernandez
-
+
MS05.01 - Epigenetic Therapeutics in Lung Cancer
11:00 - 11:15 | Presenter: Kwok-kin Wong
- Abstract
Loading... -
+
MS05.02 - Genetics Abnormalities in Chromatin Modifiers: Connection with MYC Pathway and Exploration for Therapeutics
11:15 - 11:30 | Presenter: Montse Sanchez-Cespedes
- Abstract
Loading... -
+
MS05.03 - Notch Signalling
11:30 - 11:45 | Presenter: Shirish Gadgeel
- Abstract
Loading... -
+
MS05.04 - Innate Immune Mediators in Lung Cancer
11:45 - 12:00 | Presenter: Antonio Calles Blanco
- Abstract
Loading... -
+
MS05.05 - Harnessing Oncogene Dependencies in Lung Cancer
12:00 - 12:15 | Presenter: Martin L Sos
- Abstract
Loading... -
+
MS05.06 - Q&A
12:15 - 12:30
- Abstract
No abstract available for this presentation
-
+
MS06 - An Interdisciplinary Approach to Optimal Nodal Staging
- 11:00 - 12:30
- 9/09/2019
- Location: Toronto (1985)
- IASLC CME Accredited
- Type: Mini Symposium
- Track: Staging
- Moderators:Roser Saumench Perramon, Souheil Boubia
-
+
Introduction/Poll
11:00 - 11:00
- Abstract
No abstract available for this presentation
-
+
MS06.01 - Radiologic Staging
11:00 - 11:10 | Presenter: Jin Mo Goo
- Abstract
Loading... -
+
MS06.02 - Endoscopic Nodal Staging
11:10 - 11:20 | Presenter: Jose Sanz Santos
- Abstract
Loading... -
+
MS06.03 - Pathologic Staging: Operative Events
11:20 - 11:30 | Presenter: Thomas A. D'Amico
- Abstract
Loading... -
+
MS06.04 - Approaches to Overcoming the Nodal Staging Quality Gap
11:30 - 11:40 | Presenter: Ray Osarogiagbon
- Abstract
Loading... -
+
MS06.05 - Transcervical Lymphadenectomies
11:40 - 11:50 | Presenter: Marcin Zielinski
- Abstract
Loading... -
+
MS06.06 - The Concept of Complete Resection
11:50 - 12:00 | Presenter: John G Edwards
- Abstract
Loading... -
+
MS06.07 - Q&A
12:00 - 12:30
- Abstract
No abstract available for this presentation
-
+
OA06 - Refining Lung Cancer Screening
- 11:00 - 12:30
- 9/09/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Oral Session
- Track: Screening and Early Detection
- Moderators:Tomasz Grodzki, Lluis Esteban Tejero
-
+
OA06.01 - Comparison Between Radiomics-Based Machine Learning and Deep Learning Image Classification for Sub-Cm Lung Nodules
11:00 - 11:10 | Presenter: Calum Macaulay | Author(s): Ian Janzen, Saeed Seyyedi, Ronald Abraham, Sukhinder Kaur Atkar-Khattra, John Mayo, Ren Yuan, Renelle Myers, Stephen Lam
- Abstract
Loading... -
+
OA06.02 - The Role of Simulation Modeling in Shaping Lung Cancer Screening Policies in the US and Elsewhere
11:10 - 11:20 | Presenter: Rafael Meza
- Abstract
Loading... -
+
OA06.03 - An Open Source Lung Screening Management System
11:20 - 11:30 | Presenter: Claudia I Henschke | Author(s): Anthony P Reeves, Ricardo Avila, Drew Moghanaki, Artit Jirapatnakul, David F. Yankelevitz
- Abstract
Loading... -
+
OA06.04 - Discussant - OA06.01, OA06.02, OA06.03
11:30 - 11:45 | Presenter: Betty C Tong
- Abstract
No abstract available for this presentation
-
+
OA06.05 - Evaluation of a Deep Learning-Based Automatic Classifier for the Classification of Perifissural Nodules
11:45 - 11:55 | Presenter: Daiwei Han | Author(s): Marjolein A. Heuvelmans, Mieneke Rook, Monique D. Dorrius, Luutsen Van Houten, Noah Waterfield Price, Lyndsey C Pickup, Petr Novotny, Jerome Declerck, Matthijs Oudkerk, P.M.A Van Ooijen, Fergus Gleeson, Rozemarijn Vliegenthart
- Abstract
Loading... -
+
OA06.06 - Independent Validation of a Novel High-Resolution Computed Tomography-Based Radiomic Classifier for Indeterminate Lung Nodules
11:55 - 12:05 | Presenter: Tobias Peikert | Author(s): Fenghai Duan, Srinivasan Rajagopalan, Ron Karwoski, Aneri B Balar, Dhairya Lakhani, Sanja L Antic, Brian Bartholmai, Johnson Tucker, Pierre P Massion, Fabien Maldonado
- Abstract
Loading... -
+
OA06.07 - Discrimination of Lung Invasive Adenocarcinoma with Micropapillary Pattern Based on CT Radiomics
12:05 - 12:15 | Presenter: Haihua Yang | Author(s): Yunyu Xu, Wenbin Ji, Liqiao Hou, Chao Zhou, Wei Wang, Suna Zhou, Feng-Ming Spring Kong
- Abstract
Loading... -
+
OA06.08 - Discussant - OA06.05, OA06.06, OA06.07
12:15 - 12:30 | Presenter: Jamie Ostroff
- Abstract
No abstract available for this presentation